Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Hasbani: I will Remain Committed to the Humanitarian, National and Legal Standards

 
The Information Office of Deputy Prime Minister Health Minister Ghassan Hasbani issued the following statement:

Minister Hasbani thanked the ones who call themselves “ex-Lebanese Forces members” for the statement they delivered as it enabled him to clarify the false information they gave. The medicine bill for Palestinians covered by the Ministry in 2017 was reduced to zero after the Ministry succeeded in getting the UNRWA, the UN organizations and associations fulfill their duties. The Palestinian dialysis bill covered as well by the Ministry was also reduced by 83%, while the hospitalization cases at the expenses of the Ministry were very limited, such as the critical and emergency cases that seriously threaten the lives of patients.

First: It is not true that an amount of LBP 7.5 billion was allocated yearly for the hospitalization of Palestinian patients in Lebanon during the term of Hasbani. There are three levels: the hospitalization, medicine and dialysis bills. As for hospitalization, the cases are too limited and urgent. The medicine bill has been reduced to zero in 2017, while the dialysis bill coverage included 152 non-Palestinians and 80 Palestinians in 2016 and the Ministry has succeeded in reducing the number of non-Palestinians to 20 and that of the Palestinians to half, i.e. 40.

To sum up, a comparison between 2016 and 2017 shows that the dialysis bill of Palestinians was reduced from LBP 3.2 Billion to LBP 560 million.
Second: Helping a dying Syrian child without any official identity documents at Quarantine Hospital is considered as a humanitarian honor. Is it acceptable to let a child die for the costs of his treatment are not yet provided?!! In this context, it is worth noting that the similar cases that were covered by the Ministry in 2017 are too limited and were very critical.

Third: It is not true that an employee was punished for not admitting the Syrian patient, knowing that Health Ministry is responsible for the hospitalization of the uninsured Lebanese.
 
While some people are trying to overemphasize the humanitarian role and others are keen to the public finance, the Health Minister will remain committed to the humanitarian, national and legal standards at the same time and will not be induced into their old grudges.
    5
ATC Name B/G Ingredients Dosage Form Price
A10BB12 GLUMYL 4 G Glimepiride - 4mg 4mg Tablet 317,403 L.L
A10BB12 GLYPRIDE G Glimepiride - 4mg 4mg Tablet 657,139 L.L
A10BB09 GLYZIDE G Gliclazide - 80mg 80mg Tablet 534,849 L.L
A10BB01 GLIBENCLAMIDE G Glibenclamide - 5mg 5mg Tablet, scored 340,440 L.L
A10BB01 GLIBENCLAMIDE G Glibenclamide - 5mg 5mg Tablet 326,362 L.L
A10BA02 GLUCOPHAGE B Metformin HCl - 850mg 850mg Tablet, film coated 572,634 L.L
A10BA02 GLUCOBAS G Metformin - 850mg 850mg Tablet 217,575 L.L
A10BA02 GLUFORIN 850 G Metformin HCl - 850mg 850mg Tablet, film coated 316,123 L.L
A10BA02 GLYFORMIN G Metformin HCl - 850mg 850mg Tablet 391,058 L.L
A10BA02 GLYSTOR G Metformin HCl - 850mg 850mg Tablet, film coated 454,347 L.L
A10BA02 GLUCOPHAGE B Metformin HCl - 1,000mg 1,000mg Tablet, film coated 624,963 L.L
A10BA02 GLUCOBAS G Metformin - 1000mg 1000mg Tablet 302,045 L.L
A10BA02 GLUCOPHAGE XR B Metformin HCl - 750mg 750mg Tablet, prolonged release 692,244 L.L
A10BA02 GLUFORIN XR 750 G Metformin HCl - 750mg 750mg Tablet, film coated, extended release 500,421 L.L
A10BA02 GLUCOPHAGE XR B Metformin HCl - 1000mg 1000mg Tablet, prolonged release 755,039 L.L
A10BA02 GLUFORIN XR 1000 G Metformin HCl - 1000mg 1,000mg Tablet, film coated, extended release 579,772 L.L
A10BA02 GLUCOPHAGE XR B Metformin HCl - 500mg 500mg Tablet, prolonged release 484,421 L.L
A10BA02 GLUFORIN XR 500 G Metformin HCl - 500mg 500mg Tablet, film coated, extended release 349,399 L.L
A10AE04 GLARTUS BioTech Insulin glargine - 100U/ml 100U/ml Injectable solution 1,346,530 L.L
A04AD GRAVOL B Dimenhydrinate - 15mg/5ml 15mg/5ml Liquid 258,018 L.L
A04AD GRAVOL B Dimenhydrinate - 50mg 50mg Tablet 163,949 L.L
A04AD GRAVOL B Dimenhydrinate - 100mg 100mg Suppository 294,302 L.L
A04AA02 GRANI-DENK G Granisetron - 1mg/ml 1mg/ml Injectable concentrate for solution 893,655 L.L
A04AA02 GRANI-DENK G Granisetron - 3mg/3ml 3mg/3ml Injectable concentrate for solution 1,679,803 L.L
A03FA07 GANATON B Itopride Hydrochloride - 50mg 50mg Tablet 1,119,421 L.L
A03FA07 GANATON B Itopride Hydrochloride - 50mg 50mg Tablet 357,462 L.L
A03FA07 GAROPRIDE G Itopride Hydrochloride - 50mg 50mg Tablet, film coated 213,671 L.L
A03AB02 GLYCOPYRROLATE B Glycopyronium Bromide - 0.2mg/ml 0.2mg/ml Injectable solution 7,238,185 L.L
A02BX13 GAVISCON B Sodium alginate - 500mg/10ml, Sodium bicarbonate - 267mg/10ml, Calcium (carbonate) - 160mg/10ml Liquid 295,645 L.L
A02BX13 GAVISCON INFANT B Sodium alginate - 225mg, Magnesium alginate - 87.5mg Powder for suspension 710,893 L.L
    5
Sitemap
© Copyrights reserved to Ministry of Public Health 2025